These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 2849521

  • 1. Evolution of angiotensin-converting enzyme inhibitors.
    Wyvratt MJ.
    Clin Physiol Biochem; 1988; 6(3-4):217-29. PubMed ID: 2849521
    [Abstract] [Full Text] [Related]

  • 2. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C, Cosentino E, De Sanctis D.
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [Abstract] [Full Text] [Related]

  • 3. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M.
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [Abstract] [Full Text] [Related]

  • 4. [Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors].
    Schofer J.
    Dtsch Med Wochenschr; 1988 Oct 28; 113(43):1684-9. PubMed ID: 2846252
    [No Abstract] [Full Text] [Related]

  • 5. New therapeutic prospects of renin-angiotensin system inhibition.
    Corvol P.
    Clin Exp Hypertens A; 1989 Oct 28; 11 Suppl 2():463-70. PubMed ID: 2691125
    [Abstract] [Full Text] [Related]

  • 6. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA.
    Am J Kidney Dis; 1987 Jul 28; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme inhibitors: are they all alike?
    Case DB.
    J Clin Hypertens; 1987 Sep 28; 3(3):243-56. PubMed ID: 2822859
    [Abstract] [Full Text] [Related]

  • 8. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB, Davies RO, Ferguson RK.
    Fed Proc; 1984 Apr 28; 43(5):1314-21. PubMed ID: 6323221
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 28; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 10. [Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs].
    Lazowski J.
    Wiad Lek; 1984 May 15; 37(10):792-6. PubMed ID: 6095537
    [No Abstract] [Full Text] [Related]

  • 11. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD, Ikem RT, Adigun AQ, Akintomide AO, Balogun MO, Ajayi AA.
    Cent Afr J Med; 1996 Aug 15; 42(8):253-5. PubMed ID: 8990572
    [Abstract] [Full Text] [Related]

  • 12. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R, Madonna O, Brisac AM, Benetos A, Laurent S.
    Therapie; 1998 Aug 15; 53(3):253-70. PubMed ID: 9773125
    [Abstract] [Full Text] [Related]

  • 13. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
    Cody RJ, Laragh JH, Atlas SA, Case DB.
    J Hypertens Suppl; 1983 Oct 15; 1(1):77-84. PubMed ID: 6085835
    [Abstract] [Full Text] [Related]

  • 14. [Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
    Modesti PA, Vanni S, Gensini GF.
    Ital Heart J Suppl; 2003 Aug 15; 4(8):623-34. PubMed ID: 14655458
    [Abstract] [Full Text] [Related]

  • 15. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP, Vittorio TJ, Dimayuga CA, Homma S, Rizkala A, Le Jemtel TH, Katz SD.
    Am J Cardiol; 2004 Dec 15; 94(12):1501-5. PubMed ID: 15589004
    [Abstract] [Full Text] [Related]

  • 16. Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril.
    Karlberg BE, Sjöstrand A, Ohman KP.
    J Hypertens Suppl; 1986 Dec 15; 4(5):S432-4. PubMed ID: 3033182
    [Abstract] [Full Text] [Related]

  • 17. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ.
    Am J Kidney Dis; 1987 Jul 15; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [Abstract] [Full Text] [Related]

  • 18. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
    Rahn KH.
    Z Kardiol; 1988 Jul 15; 77 Suppl 3():69-71. PubMed ID: 2850690
    [Abstract] [Full Text] [Related]

  • 19. Inhibitors of the renin-angiotensin system.
    Brunner HR, Nussberger J, Waeber B.
    Arzneimittelforschung; 1993 Feb 15; 43(2A):274-8. PubMed ID: 8498978
    [Abstract] [Full Text] [Related]

  • 20. Vasoactive peptides and hypertension: role of angiotensin converting enzyme.
    Johnston CI, Iansek R, Millar JA, McGrath BP, Matthews PG.
    Aust N Z J Med; 1981 Feb 15; 11(Suppl 1):59-63. PubMed ID: 6266379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.